Julien Dilly

11PUBLICATIONS
200CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 11, 2026
Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer.

|Aug 05, 2026
A dependency map enhanced with next-generation 3D cancer models.

|Nov 17, 2025
CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic Cancer.

Szu-Aun Long, Haley Todd, Grace Goodhart

|Jul 24, 2025
A neomorphic protein interface catalyzes covalent inhibition of RASG12D aspartic acid in tumors.

Caroline Weller, G Leslie Burnett, Lingyan Jiang

|Apr 28, 2025
Response and Resistance to RAS Inhibition in Cancer.

Richard Y Ebright, Julien Dilly, Alice T Shaw

|Jul 08, 2024
Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer.

Julien Dilly, Megan T Hoffman, Laleh Abbassi

Pageof 2

Frequent Collaborators

11 joint publications

Andrew J Aguirre

6 joint publications

Brian M Wolpin

5 joint publications

Jennifer Roth

5 joint publications

Jacqueline A M Smith